HIMS & HERS HEALTH INC HIMS

trending
Bearish

ASignal's systematic analysis rates HIMS as Bearish.

Reflects the latest available analysis · analyzed Nov 11, 2026

The case on HIMS

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong revenue growth (48.6% YoY)
  • High gross margin (64.81%) indicating pricing power
  • Free cash flow positive at $573.2M
  • High growth score (0.9) reflecting strong top-line momentum
  • RSI near oversold level (31.56), potential reversal signal
VS
Bear case
  • Negative operating and net margins
  • Negative return on equity (-40.77%) and return on assets (-3.96%)
  • High debt-to-equity ratio (4.39x)
  • Current ratio below 1 (0.92x), indicating liquidity concerns
  • MACD below signal line with negative histogram, indicating downtrend
  • Price below 20-day and 50-day SMAs, indicating weak momentum
Subscriber-only

See the full verdict on HIMS

ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.

How ASignal analyzes HIMS

Most investors never get a second opinion, let alone several. ASignal runs HIMS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

HIMS Stock: Bull vs Bear Case, Bearish Read (Nov 2026)